Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901382912> ?p ?o ?g. }
- W2901382912 endingPage "543" @default.
- W2901382912 startingPage "532" @default.
- W2901382912 abstract "Aims Demyelination, one of the major pathological changes of white matter injury, is closely related to T-cell-mediated immune responses. Thus, we investigate the role of an IL-2 monoclonal antibody (IL-2mAb, JES6-1) in combatting demyelination during the late phase of stroke. Methods IL-2mAb or IgG isotype antibody (0.25 mg/kg) was injected intraperitoneally 2 and 48 hours after middle cerebral artery occlusion (MCAO) surgery. Infarct volume, peripheral immune cell infiltration, microglia activation, and myelin loss were measured by 2,3,5-triphenyte trazoliumchloride staining, immunofluorescence staining, flow cytometry, and Western blot. Intraperitoneal CD8 neutralizing antibody (15 mg/kg) was injected 1 day before MCAO surgery to determine the role of CD8+ T cells on demyelinating lesions. Results IL-2mAb treatment reduced brain infarct volume, attenuated demyelination, and improved long-term sensorimotor functions up to 28 days after dMCAO. Brain infiltration of CD8+ T cells and peripheral activation of CD8+ T cells were both attenuated in IL-2 mAb-treated mice. The protection of IL-2mAb on demyelination was abolished in mice depleted of CD8+ T cell 1 week after stroke. Conclusions IL-2mAb preserved white matter integrity and improved long-term sensorimotor functions following cerebral ischemic injury. The activation and brain infiltration of CD8+ T cells are detrimental for demyelination after stroke and may be the major target of IL-2mAb posttreatment in the protection of white matter integrity after stroke." @default.
- W2901382912 created "2018-11-29" @default.
- W2901382912 creator A5002792067 @default.
- W2901382912 creator A5006822602 @default.
- W2901382912 creator A5024468354 @default.
- W2901382912 creator A5026465918 @default.
- W2901382912 creator A5038805449 @default.
- W2901382912 creator A5039589213 @default.
- W2901382912 creator A5046296583 @default.
- W2901382912 creator A5050774387 @default.
- W2901382912 creator A5059905480 @default.
- W2901382912 creator A5064820013 @default.
- W2901382912 creator A5069312065 @default.
- W2901382912 creator A5089693128 @default.
- W2901382912 date "2018-11-15" @default.
- W2901382912 modified "2023-10-15" @default.
- W2901382912 title "IL‐2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8 <sup>+</sup> T cells" @default.
- W2901382912 cites W1769453339 @default.
- W2901382912 cites W1937277400 @default.
- W2901382912 cites W1950515180 @default.
- W2901382912 cites W1967477376 @default.
- W2901382912 cites W1970246068 @default.
- W2901382912 cites W1971382858 @default.
- W2901382912 cites W1972128179 @default.
- W2901382912 cites W1976355501 @default.
- W2901382912 cites W1986489430 @default.
- W2901382912 cites W1990062483 @default.
- W2901382912 cites W1994579649 @default.
- W2901382912 cites W1996128058 @default.
- W2901382912 cites W1996660321 @default.
- W2901382912 cites W2003080204 @default.
- W2901382912 cites W2018062003 @default.
- W2901382912 cites W2024463373 @default.
- W2901382912 cites W2030024131 @default.
- W2901382912 cites W2033963984 @default.
- W2901382912 cites W2040579356 @default.
- W2901382912 cites W2054395536 @default.
- W2901382912 cites W2056973477 @default.
- W2901382912 cites W2061330169 @default.
- W2901382912 cites W2072528436 @default.
- W2901382912 cites W2075555809 @default.
- W2901382912 cites W2084147470 @default.
- W2901382912 cites W2094115917 @default.
- W2901382912 cites W2113948549 @default.
- W2901382912 cites W2119373327 @default.
- W2901382912 cites W2123366348 @default.
- W2901382912 cites W2142767602 @default.
- W2901382912 cites W2152070010 @default.
- W2901382912 cites W2155477484 @default.
- W2901382912 cites W2163332725 @default.
- W2901382912 cites W2202900563 @default.
- W2901382912 cites W2336345979 @default.
- W2901382912 cites W2413615017 @default.
- W2901382912 cites W2587415553 @default.
- W2901382912 cites W2759715932 @default.
- W2901382912 cites W2793152892 @default.
- W2901382912 cites W2793929159 @default.
- W2901382912 doi "https://doi.org/10.1111/cns.13084" @default.
- W2901382912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6488908" @default.
- W2901382912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30444079" @default.
- W2901382912 hasPublicationYear "2018" @default.
- W2901382912 type Work @default.
- W2901382912 sameAs 2901382912 @default.
- W2901382912 citedByCount "27" @default.
- W2901382912 countsByYear W29013829122020 @default.
- W2901382912 countsByYear W29013829122021 @default.
- W2901382912 countsByYear W29013829122022 @default.
- W2901382912 countsByYear W29013829122023 @default.
- W2901382912 crossrefType "journal-article" @default.
- W2901382912 hasAuthorship W2901382912A5002792067 @default.
- W2901382912 hasAuthorship W2901382912A5006822602 @default.
- W2901382912 hasAuthorship W2901382912A5024468354 @default.
- W2901382912 hasAuthorship W2901382912A5026465918 @default.
- W2901382912 hasAuthorship W2901382912A5038805449 @default.
- W2901382912 hasAuthorship W2901382912A5039589213 @default.
- W2901382912 hasAuthorship W2901382912A5046296583 @default.
- W2901382912 hasAuthorship W2901382912A5050774387 @default.
- W2901382912 hasAuthorship W2901382912A5059905480 @default.
- W2901382912 hasAuthorship W2901382912A5064820013 @default.
- W2901382912 hasAuthorship W2901382912A5069312065 @default.
- W2901382912 hasAuthorship W2901382912A5089693128 @default.
- W2901382912 hasBestOaLocation W29013829121 @default.
- W2901382912 hasConcept C121332964 @default.
- W2901382912 hasConcept C126322002 @default.
- W2901382912 hasConcept C169760540 @default.
- W2901382912 hasConcept C541997718 @default.
- W2901382912 hasConcept C71924100 @default.
- W2901382912 hasConcept C86803240 @default.
- W2901382912 hasConceptScore W2901382912C121332964 @default.
- W2901382912 hasConceptScore W2901382912C126322002 @default.
- W2901382912 hasConceptScore W2901382912C169760540 @default.
- W2901382912 hasConceptScore W2901382912C541997718 @default.
- W2901382912 hasConceptScore W2901382912C71924100 @default.
- W2901382912 hasConceptScore W2901382912C86803240 @default.
- W2901382912 hasFunder F4320321001 @default.
- W2901382912 hasFunder F4320321881 @default.
- W2901382912 hasFunder F4320321885 @default.
- W2901382912 hasIssue "4" @default.